Moderna CEO Stéphane Bancel: Omicron and mRNA Tech

preview_player
Показать описание
As the world faces Omicron and other potential COVID-19 variants, many are asking, are we stuck with COVID forever?

In this special episode of Exceptional Leaders / Exceptional Ideas, Matthew Harrison, Equity Analyst covering Biotechnology, sits down with Stéphane Bancel, CEO of Moderna, to discuss what it was like during the most trying periods of vaccine development, Stéphane’s views on new variants and the possibilities ahead for mRNA technology.
Рекомендации по теме
Комментарии
Автор

take moderna if you want heart problems

DigitalKapitalist
Автор

This person needs to be held accountable.

dskywalker
Автор

Did the man just dump all his stocks???

Clayton_J
Автор

What a money oriented interview. No awkward questions.
Pathetic

ballyhoo
Автор

Interesting how bancel just deleted his twitter and dumped his stock

a.b.-fv
Автор

Moderna is pathetic, hope they are bankrupt soon.

miriamful
Автор

This man is very intelligent. mRNA is a platform at its core with a ton of different avenues for revenue. This is absolutely not just a COVID company. If you have any experience in BioTech or Medicine/Pharmaceuticals, you’ll know how big this company is in changing the future of medicine. This is the Apple or Microsoft of BioTech. They built a technology platform which can scale, not just a pharma company. The fact that hedge funds are shorting this company as a pandemic stock is sad. These people are on the verge of creating therapeutics for complete cancer remission.

Nickgyw